Microbial bio-production of a recombinant stimuli-responsive biosurfactant

Biotechnology and Bioengineering

Volumn 102, Issue 1, 2009, Pages 176-187

  Kaar, W ^a   Hartmann, B M ^a   Fan, Y ^a   Zeng, B ^a   Lua, L H L ^a   Dexter, A F ^a   Falconer, R J ^a   Middelberg, A P J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Bio production; Biosurfactant; E. Coli; Maltose binding protein; Peptide; Precipitation; TEVp

Indexed keywords

BIO-PRODUCTION; BIOSURFACTANT; E. COLI; MALTOSE BINDING PROTEIN; PEPTIDE; PRECIPITATION; TEVP;

ACIDS; AIR POLLUTION; BIOMOLECULES; ENHANCED RECOVERY; ESCHERICHIA COLI; HEALTH CARE; MALTOSE; PRECIPITATION (METEOROLOGY); PROTEINS; PURIFICATION; SEMICONDUCTOR QUANTUM DOTS; SOIL CONSERVATION; SOIL POLLUTION; SURFACE ACTIVE AGENTS;

AMINES;

BIOSURFACTANT; HYBRID PROTEIN; MALTOSE BINDING PROTEIN; PEPTIDE; PEPTIDE GAM1; PROTEINASE; UNCLASSIFIED DRUG; CARRIER PROTEIN; MALTOSE-BINDING PROTEIN; SURFACTANT; TEV PROTEASE;

ACID PRECIPITATION; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PURIFICATION; STIMULUS RESPONSE; AFFINITY CHROMATOGRAPHY; CHEMISTRY; CULTURE MEDIUM; FRACTIONATION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM;

TOBACCO ETCH VIRUS;

CARRIER PROTEINS; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, AFFINITY; CULTURE MEDIA; ENDOPEPTIDASES; ESCHERICHIA COLI; RECOMBINANT FUSION PROTEINS; SURFACE-ACTIVE AGENTS;

EID: 58149265697     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.22037     Document Type: Article

References (50)

1. pro fusion technology to produce proteins with authentic N termini in E. coli. Nat Methods 4(12):1037- 1043.
2. Banat IM, Makkar RS, Cameotra SS. 2000. Potential commercial applications of microbial surfactants. Appl Microbiol Biotechnol 53(5):495- 508.
3. Birnbaum RS, Mahoney W, Roos BA. 1983. Purification and amino acid sequence of a noncalcitonin secretory peptide derived from prepro- calcitonin. J Biol Chem 258(9):5463-5466.
4. Cabrita LD, Gilis D, Robertson AL, Dehouck Y, Rooman M, Bottomley SP. 2007. Enhancing the stability and solubility of TEV protease using in silico design. Protein Sci 16(11):2360-2367.
5. Cameotra SS, Makkar RS. 2004. Recent applications of biosurfactants as biological and immunological molecules. Curr Opin Microbiol 7(3):262-266.
6. Clapes P, Infante MR. 2002. Amino acid-based surfactants: Enzymatic synthesis, properties and potential applications. Biocatal Biotransfor 20(4):215-233.
7. Cleland JL, Powell MF, Shire SJ. 1993. The development of stable protein formulations: A close look at protein aggregation, deamidation, and oxidation. Crit Rev Ther Drug 10(4):307-377.
8. Deleu M, Razafindralambo H, Popineau Y, Jacques P, Thonart P, Paquot M. 1999. Interfacial and emulsifying properties of lipopeptides from Bacillus subtilis. Colloid Surf A 152(1-2):3-10.
9. Dexter AF, Middelberg APJ. 2007. Switchable peptide surfactants with designed metal binding capacity. J Phys Chem C 111(28):10484-10492.
10. Dexter AF, Malcolm AS, Middelberg APJ. 2006. Reversible active switching of the mechanical properties of a peptide film at a fluid-fluid interface. Nat Mater 5(6):502-506.
11. Diao H, Guo C, Lin D, Zhang Y. 2007. Intein- mediated expression is an effective approach in the study of (β-defensins. Biochem Biophys Res Commun 357(4):840-846.
12. Dougherty WG, Parks TD, Cary SM, Bazan JF, Fletterick RJ. 1989. Characterization of the catalytic residues of the tobacco etch virus 49-kDa proteinase. Virology 172(1):302-310.
13. Gmehling J, Onken U. 1977. Vapor-liquid equilibrium data collection. Aqueous- organic systems. Chemistry Data Series, Vol. I, Part 1. (Behrens D, Eckermann R, series editors) Frankfurt/Main: DECHEMA. p 698.
14. Gram H, Ramage P, Memmert K, Gamse R, Kocher HP. 1994. A novel approach for high level production of a recombinant human parathyroid hormone fragment in Escherichia coli. Nat Biotechnol 12(10): 1017-1023.
15. Grangemard I, Peypoux F, Wallach J, Das BC, Labbe H, Caille A, Genest M, Maget-Dana R, Ptak M, Bonmatin JM. 1997. Lipopeptides with improved properties: Structure by NMR, purification by HPLC and structure-activity relationships of new isoleucyl-rich surfactins. J Pept Sci 3(2):145-154.
16. Gu JQ, Nguyen KT, Gandhi C, Rajgarhia V, Baltz RH, Brian P, Chu M. 2007. Structural characterization of daptomycin analogues A21978C 1-3 (D-Asn11) produced by a recombinant Streptomyces roseosporus strain. J Nat Prod 70(2):233-240.
17. Hartmann BM, Kaar W, Falconer RJ, Zeng B, Middelberg APJ. 2008. Expression and purification of a nanostructure-forming peptide. J Biotechnol 135(1):85-91.
18. Ingham AB, Moore RJ. 2007. Recombinant production of antimicrobial peptides in heterologous microbial systems. Biotechnol Appl Biochem 47(1):1-9.
19. Itakura K, Hirose T, Crea R. 1977. Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science 198(4321):1056-1063.
20. Jones DB, Middelberg APJ. 2002. Direct determination of the mechanical properties of an interfacially adsorbed protein film. Chem Eng Sci 57(10):1711-1722.
21. Kapust RB, Waugh DS. 1999. Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci 8(8):1668-1674.
22. Kapust RB, Toezser J, Fox JD, Anderson DE, Cherry S, Copeland TD, Waugh DS. 2001. Tobacco etch virus protease: Mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency. Prot Eng 14(12):993-1000.
23. Kapust RB, Tozser J, Copeland TD, Waugh DS. 2002. The P1' specificity of tobacco etch virus protease. Biochem Biophys Res Commun 294(5): 949-955.
24. Kim Y, Kim M, Kim P, Kim J. 2006. Cloning and production of a novel Bacteriocin, Lactococcin K, from Lactococcus lactis Subsp. lactis MY23. Biotechnol Lett 28(5):357-362.
25. Kuliopulos A, Walsh CT. 1994. Production, purification, and cleavage of tandem repeats of recombinant peptides. J Am Chem Soc 116(11): 4599-4607.
26. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of Bacteriophage T4. Nature 227(5259):680-685.
27. Lee EJ, Kim HS, Lee EY. 2005. Recombinant biocatalytic and cell-free synthesis of HIV fusion inhibitor. J Ind Eng Chem 11(4):515-521.
28. Lennick M, Haynes JR, Shen S-H. 1987. High-level expression of α-human atrial natriuretic peptide from multiple joined genes in Escherichia coli. Gene 61(1):103-112.
29. Liu D, Sun H, Zhang L, Li S. 2007. High-level expression of milk-derived antihypertensive peptide in Escherichia coli and its bioactivity. J Agric Food Chem 55(13):5109-5112.
30. Malcolm AS, Dexter AF, Middelberg APJ. 2006. Foaming properties of a peptide designed to form stimuli-responsive interfacial films. Soft Matter 2(12):1057-1066.
31. Middelberg APJ, He L, Dexter AF, Shen HH, Holt SA, Thomas RK. 2008. The interfacial structure and Young's modulus of peptide films having switchable mechanical properties. J Roy Soc Interf 5(18):47-54.
32. Morin K, Arcidiacono S, Beckwitt R, Mello C. 2006. Recombinant expression of indolicidin concatamers in Escherichia coli. Appl Microbiol Biotechnol 70(6):698-704.
33. Morreale G, Lee EG, Jones DB, Middelberg APJ. 2004. Bioprocess-centered molecular design (BMD) for the efficient production of an interfacially active peptide. Biotechnol Bioeng 87(7):912-923.
34. Nakayama S, Takahashi S, Hirai M, Shoda M. 1997. Isolation of new variants of surfactin by a recombinant Bacillus subtilis. Appl Microbiol Biotechnol 48(1):80-82.
35. Nallamsetty S, Kapust RB, Tözséer J, Cherry S, Tropea JE, Copeland TD, Waugh DS. 2004. Efficient site-specific processing of fusion proteins by tobacco vein mottling virus protease in vivo and in vitro. Prot Expr Purif 38(1):108-115.
36. Ohno A, Ano T, Shoda M. 1995. Production of a lipopeptide antibiotic, surfactin, by recombinant Bacillus subtilis in solid state fermentation. Biotechnol Bioeng 47(2):209-214.
37. Peypoux F, Bonmatin JM, Wallach J. 1999. Recent trends in the biochemistry of surfactin. Appl Microbiol Biotechnol 51(5):553-563.
38. Pyo S-H, Lee J-H, Park H-B, Cho J-S, Kim H-R, Han B-H, Park Y-S. 2004. Expression and purification of a recombinant buforin derivative from Escherichia coli. Process Biochem 39(11):1731-1736.
39. Reed DC, Barnard GC, Anderson EB, Klein LT, Gerngross TU. 2006. Production and purification of self-assembling peptides in Ralstonia eutropha. Prot Expr Purif 46(2):179-188.
40. Sekhon BS. 2006. Biosurfactants: An overview. Natl Acad Sci Lett 29(9-10): 317-332.
41. Shen S-H. 1984. Multiple joined genes prevent product degradation in Escherichia coli. Proc Natl Acad Sci USA 81:4627-4631.
42. Singh P, Cameotra SS. 2004. Potential applications of microbial surfactants in biomedical sciences. Trends Biotechnol 22(3):142-146.
43. Singh A, Van Hamme JD, Ward OP. 2007. Surfactants in microbiology and biotechnology. Part 2. Application aspects. Biotechnol Adv 25(1):99-121.
44. Stevens RC. 2000. Design of high-throughput methods ofprotein production for structural biology. Structure 8(9):R177-R185.
45. Van Hamme JD, Singh A, Ward OP. 2006. Physiological aspects. Part 1 in a series of papers devoted to surfactants in microbiology and biotechnology. Biotechnol Adv 24(6):604-620.
46. Walker PA, Leong LEC, Ng PWP, Tan SH, Waller S, Murphy D, Porter AG. 1994. Efficient and rapid affinity purification of proteins using recombinant fusion proteases. Bio/Technology 12(6):601-605.
47. Xu Z, Zhong Z, Huang L, Peng L, Wang F, Cen P. 2006. High-level production of bioactive human beta-defensin-4 in Escherichia coli by soluble fusion expression. Appl Microbiol Biotechnol 72(3):471- 479.
48. Xu X, Jin F, Yu X, Ji S, Wang J, Cheng H, Wang C, Zhang W. 2007. Expression and purification of a recombinant antibacterial peptide, cecropin, from Escherichia coli. Prot Expr Purif 53(2):293-301.
49. Yuan Y, Gao B, Zhu S. 2007. Functional expression of a Drosophila antifungal peptide in Escherichia coli. Prot Expr Purif 52(2):457- 462.
50. Zhou Q-F, Luo X-G, Ye L, Xi T. 2007. High-level production of a novel antimicrobial peptide perinerin in Escherichia coli by fusion expression. Curr Microbiol 54(5):366-370.